HPLC purity
Reverse-phase HPLC with UV detection; ≥99% area-purity target on each production lot.
PeptiOEM · Catalog · Cagrilintide
GLP-1 family · Engine 2 (OUS only)
Cagrilintide OEM supply.
OUS markets & research only.
Lyophilized cagrilintide (long-acting amylin analog research compound) for OUS (non-US) distribution, research labs, and private-label brand evaluation outside the United States. 99%+ HPLC purity, per-batch COA + MS.
!
OUS & research only — not for US compounding under FDA 2026 proposal
On 2026-04-30 the FDA proposed removing GLP-1 medications from the 503B bulks list, with public comment open through 2026-06-29. Pending finalization, this compound is positioned for OUS (non-US) distribution markets, research, and private-label brand evaluation only. Read the GLP-1 2026 update →
Lot CAG-5HPLC ≥ 99%MS confirmed5 / 10 mg
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Cagrilintide |
|---|---|
| Class | Long-acting amylin analog (research) |
| Molecular weight | ≈ 3884 g/mol |
| Form | Lyophilized powder, sterile glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg, 10 mg (custom on request) |
| Documentation | COA + HPLC + MS, per-batch lot file |
| Distribution scope | OUS markets & research only |
| Storage | 2–8 °C protected from light; long-term −20 °C |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | From 100 vials | 5–10 days |
| Production lot | 500–2,000 vials | 14–21 days |
| OEM repeat (OUS) | 2,000+ vials | 21–28 days, scheduled |
Cagrilintide is most often quoted alongside semaglutide in research/OUS distribution stacks. All quotes require a destination country and buyer track.
Documentation
Every Cagrilintide lot ships with a per-batch document pack.
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Cagrilintide reference profile.
Lot traceability
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Common Cagrilintide questions from B2B buyers.
Why is cagrilintide OUS-only?
On 2026-04-30 the FDA proposed removing GLP-1 medications from the 503B bulks list. While cagrilintide is an amylin analog, PeptiOEM applies the same OUS-only positioning to the broader GLP-1 family research stack pending finalization.
Is cagrilintide often paired with semaglutide?
Yes — the amylin + GLP-1 stack is a common OUS research / private-label evaluation pair. Both can be quoted together in the quote builder.
Which markets do you serve?
Latin America, Southeast Asia, parts of the Middle East, and select EMEA distributors with appropriate local registration.
What is the MOQ?
Sample lots from 100 vials; production lots from 500 vials with tier pricing.
What does your COA report?
HPLC purity (target ≥99%), MS identity, water content, related-substance profile on request, and lot traceability.
Related compounds